The day the S&P 500 Index reached its all-time high Sio Capital’s Michael Castor said the following about the coronavirus threat: “The risk is small but not negligible that coronavirus (COVID-19) will become pandemic. The virus is transmissible during the 14-day incubation period when infected carriers are asymptomatic. This is in contrast to diseases like […]

McKesson Corporation (NYSE:MCK) will release its fourth quarter fiscal 2020 financial results before market open on Wednesday, May 20, 2020. The company will host a conference call for investors at 8:00 AM Eastern Time to review its financial results.

McKesson (MCK) continues to gain traction from its multi-year strategic growth initiative and distribution solutions segment.

In this article we will check out the progression of hedge fund sentiment towards McKesson Corporation (NYSE:MCK) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and 20 […]

Cal-Maine Foods' third-quarter revenue declines Continue reading...

Q4 2020 McKesson Corp Earnings Call

Despite a significant economic downturn and a stock market pullback, a few large-cap companies in the healthcare sector managed to hold onto their positive total returns over the trailing 12-month period, observes Ned Piplovic, income expert and editor of DividendInvestor.

The number of global cases of the coronavirus that causes COVID-19 rose to 4.9 million on Wednesday and Brazil suffered its worst fatalities since the start of the outbreak, prompting President Donald Trump to say he may bar entry to flights from Brazil.

Shares of McKesson (NYSE:MCK) fell 6% in pre-market trading after the company reported Q4 results.Quarterly Results Earnings per share increased 15.72% over the past year to $4.27, which beat the estimate of $4.08.Revenue of $58,535,000,000 higher by 11.65% from the same period last year, which beat the estimate of $55,580,000,000.Outlook McKesson said it expects FY21 adjusted EPS of $13.95-$14.75, versus analysts' views of $15.46. Details Of The Call Date: May 20, 2020Time: 08:00 AMView more earnings on MCKET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestor.mckesson.com%2Fevents-and-presentations%2Fdefault.aspx&eventid=2299261&sessionid=1&key=DD18171FFEE5C2B86B39405BD2BE7063®Tag=&sourcepage=registerTechnicals 52-week high: $172.18Company's 52-week low was at $112.60Price action over last quarter: down 4.05%Company Profile McKesson is the largest and most complex of the leading third-party logistics providers. The company is engaged in wholesale pharmaceutical and medical products sourcing, distribution and dispensing, contract manufacturing, and related IT services to acute care hospitals and health systems, independent and chain retail pharmacies in North America, Europe, and Canada. Through acquisition and joint ventures McKesson also runs the fourth- largest pharmacy chain and provides technology and consulting services to manufacturers, pharmacies, physician offices, surgery centers, long-term care facilities, and home healthcare businesses.See more from Benzinga * Recap: Lowe's Companies Q1 Earnings * ShiftPixy: P/E Ratio Insights * P/E Ratio Insights for Arbutus Biopharma(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Caesars Entertainment gains on financial results Continue reading...

NEW YORK, NY / ACCESSWIRE / May 20, 2020 / McKesson Corp. (NYSE:MCK) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on May 20, 2020 at 8:00 AM Eastern Time. ...

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

McKesson Corporation (NYSE:MCK) today reported results for the fourth quarter and fiscal year ended March 31, 2020.

UPS has provided more insight into its "unprecedented" collaboration with the federal government as it fights against the coronavirus epidemic

Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of McKesson Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

MCK vs. COO: Which Stock Is the Better Value Option?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Covid-19 downturn may be an opportunity for the three big U.S. drug distributors, UBS analyst Kevin Caliende says.

The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of 41 cents per share of common stock. The dividend will be payable on July 1, 2020, to stockholders of record on June 1, 2020.

Shares of McKesson Corp. dropped 1.8% in premarket trading Wednesday, after the retail pharmacy and health care services company reported fiscal fourth-quarter earnings that beat expectations, but provided a downbeat earnings outlook citing "anticipated headwinds" as a result of the COVID-19 pandemic. The company swung to net income for the quarter to March 31 of $1.02 billion, or $5.85 a share, from a loss of $796 million, or $4.17 a share, in the year ago period. Excluding non-recurring items, adjusted earnings per share came to $4.27, beating the FactSet consensus of $4.10. Revenue rose 12% to $58.54 billion, above the FactSet consensus of $55.57 billion, as price increases for branded drugs and higher volumes from retail national account customers boosted sales at its U.S. pharmaceutical and specialty solutions business. For fiscal 2021, the company expects adjusted EPS of $13.95 to $14.75, below the FactSet consensus of $15.42. McKesson expects 2021 revenue growth of 2% to 4%, while the FactSet revenue consensus of $234.6 billion implies 1.5% growth. The stock has slumped 15.3% over the past three months, while the S&P 500 has lost 13.4%.